<SEC-DOCUMENT>0001213900-16-016696-index.html : 20160912 <SEC-HEADER>0001213900-16-016696.hdr.sgml : 20160912 <ACCEPTANCE-DATETIME>20160912152203 ACCESSION NUMBER: 0001213900-16-016696 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160909 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160912 DATE AS OF CHANGE: 20160912 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 161880954 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>f8k090916_soligenix.htm <DESCRIPTION>CURRENT REPORT <TEXT> Document 1 - file: f8k090916_soligenix.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>f8k090916ex10i_soligenix.htm <DESCRIPTION>COMMON STOCK PURCHASE AGREEMENT DATED SEPTEMBER 9, 2016 BETWEEN SOLIGENIX, INC. AND SCICLONE PHARMACEUTICALS, INC. <TEXT> Document 2 - file: f8k090916ex10i_soligenix.htm
</DOCUMENT> </SEC-DOCUMENT>